Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
about
Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cellsRosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosisAre statins diabetogenic?Pleiotropic effects of statinsBypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidusRising statin use and effect on ischemic stroke outcomeAre statins anti-inflammatory?Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular diseaseThe influence of statins on the free intracellular calcium concentration in human umbilical vein endothelial cellsVascular endothelial dysfunction and pharmacological treatmentAnticoagulants and Statins As Pharmacological Agents in Free Flap Surgery: Current RationaleEndothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic ApproachesHuman isoprenoid synthase enzymes as therapeutic targetsThe role of statins in erectile dysfunction: a systematic review and meta-analysisPrinciples of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in diseaseStatins in heart failure: do we need another trial?Role of lipotoxicity in endothelial dysfunctionStatin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial ContentHuman Vascular Microphysiological System for in vitro Drug Screening.Cholesterol, statins, and dementia: what the cardiologist should knowOngoing clinical trials of the pleiotropic effects of statinsAn association of prior statin use with decreased perihematomal edemaPrior statin use reduces mortality in intracerebral hemorrhageStatin therapy and autoimmune disease: from protein prenylation to immunomodulationPlasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adultsStatins as antioxidant therapy for preventing cardiac myocyte hypertrophyA new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acidSynergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cellsFluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritisStatin Use and Risk of Cirrhosis and Related Complications in Patients with Chronic Liver Diseases: a Systematic Review and Meta-analysis.Regulation of Transcription Factors by Reactive Oxygen Species and Nitric Oxide in Vascular Physiology and Pathology.Atherosclerosis, cholesterol, nutrition, and statins--a critical reviewLDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality?Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthaseTheragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsionsEzetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice.Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease.Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment.Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats.Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.
P2860
Q24533532-0457B9A2-E126-4CC5-B92E-3AB8257FB951Q24595023-BF2A3297-9421-42E4-ADEA-7F1850A0079EQ24630205-95AFD240-D072-47B0-90B5-6BDB80297FA1Q24647863-095BD50C-0C4E-49D6-927D-6E78B5E43962Q24650150-3F3EBF4E-FB8E-4C22-A708-A5EEA6AC4815Q24792305-910BBB1D-1D26-4F75-AD39-CAB17B790E44Q24792912-791CCFCE-891A-4738-BAEC-04DE7215D006Q24793969-1D3B8FA0-E2C1-48DA-AEA6-42B57CCF0795Q24803214-9E64D78A-39C3-44CC-9A11-0096D3ADAE89Q26774561-8EE178A7-4F41-4663-A841-4609C733AB34Q26776077-F1FDA2BF-544F-43EA-8A4A-7CC60C9AD5C2Q26785504-63905EB1-8B92-477E-9231-F6B481DE66BFQ26822639-E38EB478-AF95-4E84-8FF2-74DD49A6FA75Q26823131-0B9D6AEC-47DC-4F6B-BF7D-7F5516AB2D75Q26859449-39AAD8CA-931A-41C3-A8E1-2B9F4BA95B0FQ26998966-40A6A9D4-5AAF-4F42-8085-9822306558D0Q27000731-DE8087A4-F70E-42C6-8456-A0E7EFB3D207Q27305332-C8119DED-B2E7-4F80-A5C8-06749DE56A99Q27346581-DC077C36-2188-43ED-9026-90D001C9D184Q28081974-912D605E-CEE4-416E-9539-90C2FCBE8F52Q28219321-43B96B90-AC0C-4CDE-ABE9-911ADD54DD8EQ28219516-A2B08A18-C545-4ADF-8B4F-40D369E34821Q28219526-8F26C76B-6E9A-4434-9A29-1191385A9602Q28236647-52D36E60-7EAD-4E86-ADCE-20CFF03F2C76Q28247348-ACCD8684-A791-4874-AC37-4F13CFB2B811Q28364452-CDFD6790-3FFA-4E6C-B133-A1810B8B3DD3Q28365858-4852B08C-1C7D-4AE5-8902-90D4299B1177Q28383033-6CFC6FA3-BEF4-4E2A-AA09-4FD305BEB443Q28576951-AD4A6D5C-4A1A-4E56-A2AD-0D51A0AA3B40Q30234533-886C3846-8B03-4EDB-B005-B3CC6B99FD2FQ30275422-84F099BF-2F26-434B-97D3-EF61DE15C925Q30379837-FB6097B1-2E75-40C1-A940-99E833B3300AQ30422549-E47010E9-AF04-4E06-9F06-5AF2FF3C8B36Q30439838-754A45C2-AA56-4B0D-A708-26DA96E51EB6Q30474759-134A51C1-8E1A-4437-B29B-A564830E5520Q30547579-A3C18189-A1F0-4081-AB3A-BB53927979BEQ30829627-5A626060-B6DF-426E-8B8B-A14F779D5065Q30861585-DA3B9E5D-BFB9-40B6-A676-3391F1562488Q33358995-DD739FFB-5ECC-4668-862A-08AE00B004F0Q33571813-8A8C2FEA-88BF-4CBF-BA3C-EA6C2D1A60C8
P2860
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
@ast
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
@en
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
@nl
type
label
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
@ast
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
@en
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
@nl
prefLabel
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
@ast
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
@en
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
@nl
P2093
P1433
P1476
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
@en
P2093
P304
P356
10.1161/01.CIR.97.12.1129
P407
P577
1998-03-01T00:00:00Z